BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28802729)

  • 1. Predictors of pathologic upstaging in early esophageal adenocarcinoma: Results from the national cancer database.
    Brown CS; Gwilliam N; Kyrillos A; Lutfi W; Lapin B; Kim KW; Krantz SB; Howington JA; Yao K; Ujiki MB
    Am J Surg; 2018 Jul; 216(1):124-130. PubMed ID: 28802729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and Implications of Paratracheal Lymph Node Metastases in Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma.
    Harada K; Hwang H; Wang X; Abdelhakeem A; Iwatsuki M; Blum Murphy MA; Maru DM; Weston B; Lee JH; Rogers JE; Thomas I; Shanbhag N; Zhao M; Bhutani MS; Nguyen QN; Swisher SG; Ikoma N; Badgwell BD; Hofstetter WL; Ajani JA
    Ann Surg; 2021 Apr; 273(4):751-757. PubMed ID: 31188215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Lymph Node Metastasis in Surgically Resected T1 Esophageal Cancer.
    Dubecz A; Kern M; Solymosi N; Schweigert M; Stein HJ
    Ann Thorac Surg; 2015 Jun; 99(6):1879-85; discussion 1886. PubMed ID: 25929888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk.
    Newton AD; Predina JD; Xia L; Roses RE; Karakousis GC; Dempsey DT; Williams NN; Kucharczuk JC; Singhal S
    Ann Surg Oncol; 2018 Jan; 25(1):318-325. PubMed ID: 29147928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment allocation in patients with early-stage esophageal adenocarcinoma: Prevalence and predictors of lymph node involvement.
    Gamboa AM; Kim S; Force SD; Staley CA; Woods KE; Kooby DA; Maithel SK; Luke JA; Shaffer KM; Dacha S; Saba NF; Keilin SA; Cai Q; El-Rayes BF; Chen Z; Willingham FF
    Cancer; 2016 Jul; 122(14):2150-7. PubMed ID: 27142247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Model Based on Pathologic Features of Superficial Esophageal Adenocarcinoma Complements Clinical Node Staging in Determining Risk of Metastasis to Lymph Nodes.
    Davison JM; Landau MS; Luketich JD; McGrath KM; Foxwell TJ; Landsittel DP; Gibson MK; Nason KS
    Clin Gastroenterol Hepatol; 2016 Mar; 14(3):369-377.e3. PubMed ID: 26515637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of lymph node status in superficial esophageal carcinoma.
    Ancona E; Rampado S; Cassaro M; Battaglia G; Ruol A; Castoro C; Portale G; Cavallin F; Rugge M
    Ann Surg Oncol; 2008 Nov; 15(11):3278-88. PubMed ID: 18726651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy.
    Samson P; Puri V; Robinson C; Lockhart C; Carpenter D; Broderick S; Kreisel D; Krupnick AS; Patterson GA; Meyers B; Crabtree T
    Ann Thorac Surg; 2016 Jun; 101(6):2102-11. PubMed ID: 27083246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining Pathologic Upstaging in cT1b Esophageal Cancer: Should We Consider Neoadjuvant Therapy?
    Mann DR; Engelhardt KE; Gibney BC; Batten ME; Klipsch EC; Mukherjee R; Bostock IC
    J Surg Res; 2024 Mar; 295():61-69. PubMed ID: 37992454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b sm2-3): the frequency of lymph-node metastasis depends on macroscopic and histological risk patterns.
    Manner H; Wetzka J; May A; Pauthner M; Pech O; Fisseler-Eckhoff A; Stolte M; Vieth M; Lorenz D; Ell C
    Dis Esophagus; 2017 Feb; 30(3):1-11. PubMed ID: 26952572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship Between the Size of Metastatic Lymph Nodes and Positron Emission Tomographic/Computer Tomographic Findings in Patients with Esophageal Squamous Cell Carcinoma.
    Park SY; Kim DJ; Jung HS; Yun MJ; Lee JW; Park CK
    World J Surg; 2015 Dec; 39(12):2948-54. PubMed ID: 26324159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes and benefits for staging of surgical lymph node mapping after esophagectomy.
    Lagarde SM; Phillips AW; Navidi M; Disep B; Griffin SM
    Dis Esophagus; 2017 Dec; 30(12):1-7. PubMed ID: 28881884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical evaluation of lymph nodes in esophageal adenocarcinoma: Standardized approach or personalized medicine?
    Tsai TC; Miller J; Andolfi C; Whang B; Fisichella PM
    Eur J Surg Oncol; 2018 Aug; 44(8):1177-1180. PubMed ID: 29751947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extent of lymph node removal during esophageal cancer surgery and survival.
    van der Schaaf M; Johar A; Wijnhoven B; Lagergren P; Lagergren J
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25748792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node ratio is a significant predictor of disease-specific mortality in patients undergoing esophagectomy for cancer.
    Fox M; Farmer R; Scoggins CR; McMasters KM; Martin RC
    Am Surg; 2012 May; 78(5):528-34. PubMed ID: 22546123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy.
    Nigro JJ; DeMeester SR; Hagen JA; DeMeester TR; Peters JH; Kiyabu M; Campos GM; Oberg S; Gastal O; Crookes PF; Bremner CG
    J Thorac Cardiovasc Surg; 1999 May; 117(5):960-8. PubMed ID: 10220691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Nodal Upstaging in Clinical Node Negative Patients With Penile Carcinoma: A National Cancer Database Analysis.
    Winters BR; Mossanen M; Holt SK; Lin DW; Wright JL
    Urology; 2016 Oct; 96():29-34. PubMed ID: 27450944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the National Cancer Database to create a scoring system that identifies patients with early-stage esophageal cancer at risk for nodal metastases.
    Weksler B; Kennedy KF; Sullivan JL
    J Thorac Cardiovasc Surg; 2017 Nov; 154(5):1787-1793. PubMed ID: 28867381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel node navigation surgery is acceptable for clinical T1 and N0 esophageal cancer.
    Uenosono Y; Arigami T; Yanagita S; Kozono T; Arima H; Hirata M; Kita Y; Uchikado Y; Okumura H; Matsumoto M; Natsugoe S
    Ann Surg Oncol; 2011 Jul; 18(7):2003-9. PubMed ID: 21503793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total number of resected lymph nodes predicts survival in esophageal cancer.
    Altorki NK; Zhou XK; Stiles B; Port JL; Paul S; Lee PC; Mazumdar M
    Ann Surg; 2008 Aug; 248(2):221-6. PubMed ID: 18650631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.